Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations

Key Points

• The research aims to explore the clinical applications of psychedelic-assisted therapies and the barriers to their implementation.
• Review of late-stage clinical trial outcomes
• Analysis of regulatory and ethical frameworks
• Evaluation of challenges in workforce training and accessibility
• Psychedelic therapies show promise for high-need populations in late-stage trials.
• Key challenges include ensuring long-term safety and scalability.
• Regulatory considerations are essential for ethical implementation.

Abstract